Legend Biotech Corporation (LEGN) Earnings History
Annual and quarterly earnings data from 2017 to 2025
Loading earnings history...
LEGN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LEGN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 60.3% | -13.3% | -28.8% |
| 2024 | 62.6% | -48.3% | -28.2% |
| 2023 | 49.4% | -154.1% | -181.8% |
| 2022 | 44.1% | -389.4% | -381.5% |
| 2021 | 100.0% | -570.0% | -586.4% |
Download Data
Export LEGN earnings history in CSV or JSON format
Free sign-in required to download data
Legend Biotech Corporation (LEGN) Earnings Overview
As of May 8, 2026, Legend Biotech Corporation (LEGN) reported trailing twelve-month net income of -$297M, reflecting -66.0% year-over-year growth. The company earned $-3.22 per diluted share over the past four quarters, with a net profit margin of -28.8%.
Looking at the long-term picture, LEGN's historical earnings data spans multiple years. The company achieved its highest annual net income of $9M in fiscal 2017.
Legend Biotech Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FATE (-$136M net income, -2051.1% margin), CRSP (-$569M net income, -16569.8% margin), BEAM (-$65M net income, -57.2% margin), LEGN has outperformed on profitability metrics. Compare LEGN vs FATE →
LEGN Earnings vs Peers
Earnings metrics vs comparable public companies
LEGN Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$298M | -68.1% | -$137M | $-3.22 | -28.8% | -13.3% |
| 2024 | -$177M | +65.8% | -$303M | $-1.94 | -28.2% | -48.3% |
| 2023 | -$518M | -16.1% | -$439M | $-5.88 | -181.8% | -154.1% |
| 2022 | -$446M | -10.6% | -$456M | $-5.62 | -381.5% | -389.4% |
| 2021 | -$404M | -51.5% | -$392M | $-5.48 | -586.4% | -570.0% |
| 2020 | -$266M | -162.2% | $0 | $-5.14 | -355.2% | 0.0% |
| 2019 | -$102M | -3549.1% | -$133M | $-2.02 | -164.4% | -214.4% |
| 2018 | -$3M | -129.7% | -$2M | $-0.06 | -5.7% | -3.1% |
| 2017 | $9M | - | $14M | $0.14 | 39.7% | 58.4% |
See LEGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LEGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LEGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLEGN — Frequently Asked Questions
Quick answers to the most common questions about buying LEGN stock.
Is LEGN growing earnings?
LEGN EPS fell to $-3.22, with earnings declining -66.0%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-297M.
What are LEGN's profit margins?
Legend Biotech Corporation net margin is -28.8%, with operating margin at -13.3%. Below-average margins reflect competitive or cost pressures.
How consistent are LEGN's earnings?
LEGN earnings data spans 2017-2025. The declining earnings trend is -66.0% YoY. Historical data enables comparison across business cycles.